参考文献/References:
[1] van Dieren S,Beulens JW,van der Schouw YT,et al.The global burden of diabetes and its complications:an emerging pandemic[J].Eur J Cardiovasc Prev Rehabil,2010,17(Suppl 1):S3-S8.
[2] Devrajani BR,Shah SZ,Soomro AA,et al.Type 2 diabetes mellitus:A riskfactor for Helicobacter pylori infection:A hospital based case-control study[J].Int J Diabetes Dev Ctries,2010,30(1):22-26.
[3] Jeon CY,Haan MN,Cheng C,et al.Helicobacter pylori infection is associated with an increased rate of diabetes[J].Diabetes Care,2012,35(3):520-525.
[4] Anastasios R,Goritsas C,Papamihail C,et al.Helicobacter pylori infection in diabetic patients:prevalence and endoscopic findings[J].Eur J Intern Med,2002,13(6):376.
[5] Demir M,Ookturk HS,Ozturk NA,et al.Helicobacter pyiori prevalencein diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications[J].Dig Dis Sci,2008,53(10):2646-2649.
[6] Simon L,Tornóczky J,Tóth M,et al.The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice[J].Orv Hetil,1989,130(25):1325-1329.
[7] Zhou X,Zhang C,Wu J,et al.Association between Helicobacter pyloriinfection and diabetes mellitus:a meta-analysis of observational studies[J].Diabetes Res Clin Pract,2013,99(2):200-208.
[8] Chen Y,Blaser MJ.Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels[J].J Infect Dis,2012,205(8):1195-1202.
[9] Lutsey PL,Pankow JS,Bertoni AG,et al.Serological evidence of infections and Type 2 diabetes:the Multiethnic Study of Atherosclerosis[J].Diabet Med,2009,26(2):149-152.
[10] Xia HH,Talley NJ,Kam EP,et al.Helicobacter pylori infection is not associated with diabetes mellitus,nor with upper gastrointestinal symptoms in diabetes mellitus[J].Am J Gastroenterol,2001,96(4):1039-1046.
[11] Oluyemi A,Anomneze E,Smith S,et al.Prevalence of a marker of activeHelicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos,Nigeria[J].BMC Res Notes,2012,5(1):284.
[12] Demir M,Gokturk HS,Ozturk NA,et al.Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship toglycemic control and late complications[J].Dig Dis Sci,2008,53(10):2646-2649.
[13] Borody T,Ren Z,Pang G,et al.Impaired host immunity contributes to Helicobacter pylori eradication failure[J].Am J Gastroenterol,2002,97(12):3032-3037.
[14] Donath MY,Shoelson SE.Type 2 diabetes as an inflammatory disease[J].Nat Rev Immunol,2011,11(2):98-107.
[15] Polyzos SA,Kountouras J,Zavos C,et al.The association between Helicobacter pylori infection and insulin resistance:a systematic review[J].Helicobacter,2011,16(2):79-88.
[16] Gunji T,Matsuhashi N,Sato H,et al.Helicobacter pylori infectionsignificantly increases insulin resistance in the asymptomatic Japanese population[J].Helicobacter,2009,14(5):496-502.
[17] Aydemir S, Bayraktaroglu T, Sert M,et al.The effect of Helicobacter pylori on insulin resistance[J].Dig Dis Sci,2005,50(11):2090-2093.
[18] Gillum RF.Infection with Helicobacter pylori,coronary heart disease,cardiovascular risk factors,and systemic inflammation:the Third National Health and Nutrition Examination Survey[J].J Natl Med Assoc,2004,96(11):1470-1476.
[19] Park SH,Jeon WK,Kim SH,et al.Helicobacter pylori eradication hasno effect on metabolic and inflammatory parameters[J].J Natl Med Assoc,2005,97(4):508-513.
[20] Fernández-Real JM,Pickup JC.Innate immunity,insulin resistance andtype 2 diabetes[J].Trends Endocrinol Metab,2008,19(1):10-16.
[21] Dinarello CA, Donath MY, Mandrup-Poulsen T.Role of IL-1beta in type2 diabetes[J].Curr Opin Endocrinol Diabetes Obes,2010,17(4):314-321.
[22] Shoelson SE,Lee J,Goldfine AB.Inflammation and insulin resistance[J].J Clin Invest,2006,116(7):1793-1801.
[23] Misiewicz JJ.Current insights in the pathogenesis of Helicobacter pylori infection[J].Eur J Gastroenterol Hepatol,1995,7(7):701-703.
[24] Greenberg AS,Nordan RP,McIntosh J,et al.Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes:a possible role for interleukin 6 in cancer cachexia[J].Cancer Res,1992,52(15):4113-4116.
[25] Laaksonen DE,Niskanen L,Nyyss(¨overo)nen K,et al.C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men[J].Diabetologia,2004,47(8):1403-1410.
[26] Lassenius MI,Pietil(¨overa)inen KH,Kaartinen K,et al.Bacterial endotoxin activity in human serum is associated with dyslipidemia,insulin resistance,obesity,and chronic inflammation[J].Diabetes Care,2011,34(8):1809-1815.
[27] Jeffery PL,McGuckin MA,Linden SK.Endocrine impact of Helicobacter pylori:focus on ghrelin and ghrelin o-acyltransferase[J].World J Gastroenterol,2011,17(10):1249-1260.
[28] Kaneko H,Konagaya T,Kusugami K.Helicobacter pylori and gut hormones[J].J Gastroenterol,2002,37(2):77-86.
[29] Peach HG,Barnett NE.Helicobacter pylori infection and fasting plasma glucose concentration[J].J Clin Pathol,2001,54(6):466-469.
[30] Acbay O,Celik AF,Gündo(ˇoverg)du S.Does Helicobacter pylori induced gastritis enhance food-stimulated insulin release[J].Dig Dis Sci,1996,41(7):1327-1331.
[31] Verhulst PJ, Depoortere I. Ghrelin's second life:from appetite stimulator to glucose regulator[J].World J Gastroenterol,2012,18(25):3183-3195.
[32] Tsch(¨overo)p M,Smiley DL,Heiman ML.Ghrelin induces adiposity in rodents[J].Nature,2000,407(686):908-913.
[33] Halaas JL, Gajiwala KS, Maffei M,et al.Weight-reducing effects of the plasma protein encoded by the obese gene[J].Science,1995,269(5223):543-546.
[34] Osawa H,Nakazato M,Date Y,et al.Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori[J].J Clin Endocrinol Metab,2005,90(1):10-16.
[35] Nishi Y,Isomoto H,Uotani S,et al.Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection[J].World J Gastroenterol,2005,11(5):695-699.
[36] P(¨overo)ykk(¨overo)SM, Kellokoski E, H(¨overo)rkk(¨overo)S,et al.Low plasma ghrelin is associated with insulin resistance,hypertension,and the prevalence of type 2 diabetes[J].Diabetes,2003,52(10):2546-2553.
[37] Cohen B,Novick D,Rubinstein M.Modulation of insulin activities by leptin[J].Science,1996,274(5290):1185-1188.
[38] Rahman MA,Cope MB,Sarker SA,et al.Helicobacter pylori infectionand inflammation:implication for the pathophysiology of diabetes and coronary heart disease in asian indians[J].J Life Sci,2009,1(1):45-50.
[39] Ojetti V,Pellicano R,Fagoonee S,et al.Helicobacter pylori infection and diabetes[J].Minerva Med,2010,101(2):115-119.
[40] Lee YH,Magkos F,Mantzoros CS,et al.Effects of leptin and adiponectinon pancreatic β-cell function[J].Metabolism Clinical & Experimental,2011,60(12):1664-1672.
相似文献/References:
[1]赵 枰,段义农,张秀琳.口腔与胃内幽门螺杆菌感染的相关性[J].现代检验医学杂志,2016,31(02):112.[doi:10.3969/j.issn.1671-7414.2016.02.033]
ZHAO Ping,DUAN Yi-nong,ZHANG Xiu-lin.Study on the Association between Helicobacter Pylori Infection
in Oral Cavity and Gastric Helicobacter Pylori Infection[J].Journal of Modern Laboratory Medicine,2016,31(01):112.[doi:10.3969/j.issn.1671-7414.2016.02.033]
[2]余安运,刘夏炎,宋 煜,等.血清脂蛋白(a)和同型半胱氨酸(HCY)
与2型糖尿病胰岛素抵抗的临床研究[J].现代检验医学杂志,2016,31(03):65.[doi:10.3969/j.issn.1671-7414.2016.03.018]
YU An-yun,LIU Xia-yan,SONG Yu,et al.Clinical Study of Serum Lipoprotein(a)
and Homocysteine with Type 2 Diabetes Mellitus and Insulin Resistance[J].Journal of Modern Laboratory Medicine,2016,31(01):65.[doi:10.3969/j.issn.1671-7414.2016.03.018]
[3]李 礼,胡娟玉,于正清.IL-19在2型糖尿病患者中的
表达及与血管病变的关系[J].现代检验医学杂志,2016,31(03):92.[doi:10.3969/j.issn.1671-7414.2016.03.025]
LI Li,HU Juan-yu,YU Zheng-qing.Expression of Interleukin-19 and Its Relationship
with Angiopathy in 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2016,31(01):92.[doi:10.3969/j.issn.1671-7414.2016.03.025]
[4]王继贵.基质金属蛋白酶和代谢综合征的研究进展[J].现代检验医学杂志,2015,30(03):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
WANG Ji-gui.Progress of Research on Matrix Metalloproteinases and Metabolic Syndrome[J].Journal of Modern Laboratory Medicine,2015,30(01):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
[5]李秋馨,付玉梅,梁志舜,等.5种幽门螺杆菌检测方法的比较[J].现代检验医学杂志,2015,30(05):127.[doi:10.3969/j.issn.1671-7414.2015.05.039]
LI Qiu-xin,FU Yu-mei,LIANG Zhi-shun,et al.Comparison of 5 Kinds of Detection Methods for Helicobacter Pylori[J].Journal of Modern Laboratory Medicine,2015,30(01):127.[doi:10.3969/j.issn.1671-7414.2015.05.039]
[6]李晓华,王养维,李晓燕,等.幽门螺杆菌感染与2型糖尿病下肢动脉粥样硬化病变的相关性研究[J].现代检验医学杂志,2015,30(06):13.[doi:10.3969/j.issn.1671-7414.2015.06.004]
LI Xiao-hua,WANG Yang-wei,LI Xiao-yan,et al.Study on Correlation between Helicobacter
Pylori Infection and Lower Limb Artery Atherosclerotic
Lesions of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2015,30(01):13.[doi:10.3969/j.issn.1671-7414.2015.06.004]
[7]李 妮,佘菲菲.幽门螺杆菌功能性oipA基因的检测及意义[J].现代检验医学杂志,2015,30(01):42.[doi:10.3969/j.issn.1671-7414.2015.01.012]
LI Ni,SHE Fei-fei.Detection of Helicobacter Pylori Functional
OipA Gene and Its Significance[J].Journal of Modern Laboratory Medicine,2015,30(01):42.[doi:10.3969/j.issn.1671-7414.2015.01.012]
[8]李国春a,曹 娜a,王 忆b,等.基础血尿酸水平与糖负荷后胰岛素分泌相关性研究[J].现代检验医学杂志,2015,30(02):105.[doi:10.3969/j.issn.1671-7414.2015.02.032]
LI Guo-chuna,CAO Naa,WANG Yib,et al.Relationship between Concentration of Fasting Uric
Acid and Insulin Secretion after Glycemia Burden[J].Journal of Modern Laboratory Medicine,2015,30(01):105.[doi:10.3969/j.issn.1671-7414.2015.02.032]
[9]侯媛媛,李 妮,张莎莎,等.幽门螺杆菌感染与强直性脊柱炎的关系初探[J].现代检验医学杂志,2016,31(05):140.[doi:10.3969/j.issn.1671-7414.2016.05.041]
[10]刘彦君a,梁君蓉b,庞晓宁a.血清趋化素及hs-CRP水平对2型糖尿病患者无症状亚临床动脉粥样硬化诊断的临床意义[J].现代检验医学杂志,2017,32(02):36.[doi:10.3969/j.issn.1671-7414.2017.02.010]
LIU Yan-juna,LIANG Jun-rongb,PANG Xiao-ninga.Clinical Significance of Serum Chemerin and hs-CRP in the Diagnosis
of Subclinical Atherosclerosis in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2017,32(01):36.[doi:10.3969/j.issn.1671-7414.2017.02.010]